Literature DB >> 29926339

Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy.

Mohsen Saleh ElAlfy1, Amira Abdel Moneam Adly1, Fatma Soliman ElSayed Ebeid1, Deena Samir Eissa2, Eman Abdel Rahman Ismail3, Yasser Hassan Mohammed4, Manar Elsayed Ahmed1, Aya Sayed Saad4.   

Abstract

Sickle cell disease (SCD) is associated with alterations in immune phenotypes. CD4+CD28null T lymphocytes have pro-inflammatory functions and are linked to vascular diseases. To assess the percentage of CD4+CD28null T lymphocytes, natural killer cells (NK), and IFN-gamma levels, we compared 40 children and adolescents with SCD with 40 healthy controls and evaluated their relation to disease severity and response to therapy. Patients with SCD steady state were studied, focusing on history of frequent vaso-occlusive crisis, hydroxyurea therapy, and IFN-gamma levels. Analysis of CD4+CD28null T lymphocytes and NK cells was done by flow cytometry. Liver and cardiac iron overload were assessed. CD4+CD28null T lymphocytes, NK cells, and IFN-gamma levels were significantly higher in patients than controls. Patients with history of frequent vaso-occlusive crisis and those with vascular complications had higher percentage of CD4+CD28null T lymphocytes and IFN-gamma while levels were significantly lower among hydroxyurea-treated patients. CD4+CD28null T lymphocytes were positively correlated to transfusional iron input while these cells and IFN-gamma were negatively correlated to cardiac T2* and duration of hydroxyurea therapy. NK cells were correlated to HbS and indirect bilirubin. Increased expression of CD4+CD28null T lymphocytes highlights their role in immune dysfunction and pathophysiology of SCD complications.

Entities:  

Keywords:  CD4+CD28null T lymphocytes; Hydroxyurea; Immune dysfunction; Iron overload; Natural killer cells; Sickle cell disease

Mesh:

Substances:

Year:  2018        PMID: 29926339     DOI: 10.1007/s12026-018-9010-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  53 in total

Review 1.  Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance.

Authors:  D L Wethers
Journal:  Am Fam Physician       Date:  2000-09-01       Impact factor: 3.292

2.  Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice.

Authors:  J David Holtzclaw; Daniel Jack; Samuel M Aguayo; James R Eckman; Jesse Roman; Lewis L Hsu
Journal:  Am J Respir Crit Care Med       Date:  2003-12-18       Impact factor: 21.405

3.  High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.

Authors:  Ingrid E Dumitriu; Paramita Baruah; Caroline J Finlayson; Ian M Loftus; Ricardo F Antunes; Pitt Lim; Nicholas Bunce; Juan Carlos Kaski
Journal:  Circ Res       Date:  2012-01-26       Impact factor: 17.367

Review 4.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

Review 5.  CD4+ CD28 null T cells in coronary artery disease: when helpers become killers.

Authors:  Ingrid E Dumitriu; Ernesto Trallero Araguás; Christina Baboonian; Juan Carlos Kaski
Journal:  Cardiovasc Res       Date:  2008-09-25       Impact factor: 10.787

6.  Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Authors:  Robert S Nickel; Ifeyinwa Osunkwo; Aneesah Garrett; Jennifer Robertson; David R Archer; Daniel E L Promislow; John T Horan; Jeanne E Hendrickson; Leslie S Kean
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

7.  The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease; Haemoglobinopathy.

Authors:  Ted Wun
Journal:  Hematology       Date:  2001       Impact factor: 2.269

8.  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Authors:  Joshua J Field; Gene Lin; Maureen M Okam; Elaine Majerus; Jeffrey Keefer; Onyinye Onyekwere; Ainsley Ross; Federico Campigotto; Donna Neuberg; Joel Linden; David G Nathan
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

Review 9.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

10.  Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Adedoyin Dosunmu; Adewumi Adediran; Olajumoke Oshinaike; Phillip Adebola; Olanrewaju Arogundade
Journal:  BMC Res Notes       Date:  2012-08-01
View more
  2 in total

1.  Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.

Authors:  Nadja Pinto Garcia; Alexander Leonardo S Júnior; Geyse Adriana S Soares; Thainá Cristina C Costa; Alicia Patrine C Dos Santos; Allyson Guimarães Costa; Andréa Monteiro Tarragô; Rejane Nina Martins; Flávia do Carmo Leão Pontes; Emerson Garcia de Almeida; Erich Vinícius de Paula; Olindo Assis Martins-Filho; Adriana Malheiro
Journal:  J Immunol Res       Date:  2020-01-08       Impact factor: 4.818

2.  Inflammatory Dendritic Cells Contribute to Regulate the Immune Response in Sickle Cell Disease.

Authors:  Renata Sesti-Costa; Marina Dorigatti Borges; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Sara Terezinha Olalla Saad; Fernando Ferreira Costa
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.